Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab.
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2014
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Musculoskeletal pain; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 07 Jun 2017 Biomarkers information updated
- 03 Jan 2013 Planned number of patients changed from 160 to 240 as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.